Barely Significant
← all excerpts

Teprotumumab: A Review in Thyroid Eye Disease.

Drugs · 2022 · PMC9718703 · PMID 36418673

1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

difference was apparentp < 0.001actually significant
This treatment difference was apparent from week 6 in the phase II study ( p < 0.001) [ 15 ].

also in 830 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.